State Of Alaska, Department Of Revenue Arrowhead Pharmaceuticals, Inc. Transaction History
State Of Alaska, Department Of Revenue
- $9.79 Billion
- Q3 2025
A detailed history of State Of Alaska, Department Of Revenue transactions in Arrowhead Pharmaceuticals, Inc. stock. As of the latest transaction made, State Of Alaska, Department Of Revenue holds 69,568 shares of ARWR stock, worth $2.68 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
69,568
Previous 74,819
7.02%
Holding current value
$2.68 Million
Previous $1.18 Million
103.13%
% of portfolio
0.02%
Previous 0.01%
Shares
24 transactions
Others Institutions Holding ARWR
# of Institutions
327Shares Held
99.7MCall Options Held
444KPut Options Held
568K-
Black Rock Inc. New York, NY15.7MShares$603 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA15.5MShares$597 Million0.0% of portfolio
-
Avoro Capital Advisors LLC New York, NY10.6MShares$408 Million3.05% of portfolio
-
State Street Corp Boston, MA6.37MShares$245 Million0.0% of portfolio
-
Slate Path Capital LP New York, NY5.23MShares$201 Million1.65% of portfolio
About ARROWHEAD PHARMACEUTICALS, INC.
- Ticker ARWR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 105,849,000
- Market Cap $4.07B
- Description
- Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...